- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05176600
Bimanual Robotic Exoskeletal Platform for the Treatment of the Upper Limb in Patients With Stroke. A Feasibility Study (Birehab)
Pilot Study on the Evaluation of the Functionality, Safety and Feasibility of a Bimanual Robotic Exoskeletal Platform for the Treatment of the Upper Limb in Patients With Stroke
The purpose of the study is to test the technical functionality, safety, and feasibility of a bimanual robotic exoskeletal platform and associated serious games in order to offer information on technological and functional advances that will be included in the device's finalization.
In addition, a secondary goal will be to assess the therapeutic effects of a rehabilitation therapy based on the bimanual configuration, comparing it to a unimanual treatment delivered on the same platform (using the specific configuration).
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Irene Aprile, MD, PhD
- Phone Number: +390633086553
- Email: iaprile@dongnocchi.it
Study Locations
-
-
-
Rome, Italy, 00168
- Recruiting
- Fondazione Don Carlo Gnocchi
-
Contact:
- Irene Aprile, MD, PhD
- Phone Number: +390688036553
- Email: iaprile@dongnocchi.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- height between 150 and 190 cm;
- weight not exceeding 130 kg;
- ischemic injury;
- first cortical and supra-tentorial event;
- moderate motor deficit of the upper limb (score on the Fugl-Meyer Assessment - Upper Extremity between 29 and 42);
- time since stroke event between 1 and 6 months;
- trunk control test score greater than or equal to 48;
- healthy bone density and skeleton that does not suffer from unhealed fractures.
Exclusion Criteria:
- Relevant medical comorbidities (severe neurological diseases, cardiovascular diseases, diabetes / unstabilized hypertension);
- Cognitive impairment that prevents understanding of the exercises administered;
- Unavailability to provide informed consent;
- Pregnant women;
- Severe spasticity (Ashworth 4);
- Major muscle contractures;
- Excessive asymmetry in the length of the arms;
- Upper limb prostheses;
- Excessive joint limitations that make it difficult or painful to use the device;
- Use of pacemakers or implantation of active devices;
- Patients who already participate in another clinical study or who are already undergoing another similar robotic rehabilitation treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bimanual group
In this group, patients will perform a robotic rehabilitation based on bimanual serious games
|
Patients will undergo a bimanual 30-session robotic rehabilitation, using the robot ALEx RS with the bimanual configuration and the related serious games.
Each session will last 45 minute.
Daily sessions will be provided, five days a week.
|
|
Active Comparator: Unimanual group
In this group, patients will perform a robotic rehabilitation based on unimanual serious games
|
Patients will undergo a unimanual 30-session robotic rehabilitation, using the robot ALEx RS with the unimanual configuration and the related serious games.Daily sessions will be provided, five days a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of adverse events and description
Time Frame: through the study, an average of 10 months
|
Number and description of adverse events related to the provided intervention
|
through the study, an average of 10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale
Time Frame: After a 6-week robotic rehabilitation intervention
|
It is a self-administered questionnaire to evaluate usability.
It ranges from 0 to 100.
Higher scores mean better usability.
|
After a 6-week robotic rehabilitation intervention
|
|
Technology Acceptance Model (TAM)
Time Frame: After a 6-week robotic rehabilitation intervention
|
It is a self-administered questionnaire to evaluate the acceptance of the provided. It comprises several questions rated on a 7-point likert scale. |
After a 6-week robotic rehabilitation intervention
|
|
Likert for Satisfaction
Time Frame: After a 6-week robotic rehabilitation intervention
|
Satisfaction will be assessed using a 11-point likert scale.
It ranges from 0 to 10. Higher scores mean higher satisfaction.
|
After a 6-week robotic rehabilitation intervention
|
|
Changes in Fugl-meyer Assessment Upper Extremity motor functioning
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a stroke-specific, performance-based impairment index.
It ranges from 0 (hemiplegia) to 66 points (normal).
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Action Research Arm Test (ARAT)
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a valid measure of upper-extremity functional limitation.
The total score on the ARAT ranges from 0 to 57, with the lowest score indicating that no movements can be performed, and the upper score indicating normal performance.
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Motricity Index for upper extremity
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a validated measure of upper limb strength.
It ranges from 0 (worse) to 100 (normal strength).
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in EEG-based Interhemispheric coupling index
Time Frame: Before the intervention, after a 1-hour robotic rehabilitation session
|
Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)
|
Before the intervention, after a 1-hour robotic rehabilitation session
|
|
Changes in EEG-based Interhemispheric coupling index
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in EEG-based Interhemispheric coupling index
Time Frame: Before the intervention, 1 week after the end of the 30-session robotic intervention
|
Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)
|
Before the intervention, 1 week after the end of the 30-session robotic intervention
|
|
Changes in EEG-based Connectivity index
Time Frame: Before the intervention, after a 1-hour robotic rehabilitation session
|
Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)
|
Before the intervention, after a 1-hour robotic rehabilitation session
|
|
Changes in EEG-based Connectivity index
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in EEG-based Connectivity index
Time Frame: Before the intervention, 1 week after the end of the 30-session robotic intervention
|
Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)
|
Before the intervention, 1 week after the end of the 30-session robotic intervention
|
|
Changes in Fugl-meyer Assessment - Sensory functioning
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a stroke-specific, sensory impairment index.
It ranges from 0 (worse) to 12points (best).
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Modified Ashworth Scale
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a validated measure of spasticity.
It ranges from 0 (normal) to 4 (rigid limb).
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Wolf Motor Function Test
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a validated measure of upper extremity motor ability through timed and functional tasks. The scores ranges from 0 to 75; lower scores are indicative of lower functioning levels. |
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Execution time (seconds) measured with the robot
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is the time (in seconds) required to perform reaching movement using the robot
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Range of Motion (degrees) measured with the robot
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is the range of motion (measured in degrees) of shoulder and elbow evaluated using the robot
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
|
Changes in Number of velocity peaks measured with the robot
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
|
It is a measure of movement smoothness while performing reaching movements with the robot.
|
Before the intervention, after a 6-week robotic rehabilitation intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDG_Birehab_2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and bimanual serious games
-
Wearable Robotics srl.Azienda Ospedaliero, Universitaria Pisana; University Hospital, Geneva; Ecole...Terminated